3rd Quarter - Report
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R.6642: "to sunset the limit on maximum rebate amount for single source drugs".
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Education about innovative contracting and value based payments. Education about the 340(b) drug discount program including the CMS 340(b) CMP Rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Budget/Appropriations BUD
H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.